Schedule 13G ownership disclosure

CRINETICS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 22663K107

Event date: 2021-04-19

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.0500%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-21-001031
Form type
SC 13G
Filer
Crinetics Pharmaceuticals, Inc.
CIK
CIK 1658247
Filed
Apr 22, 2021
Reporting period
Apr 19, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub